Nabriva Therapeutics plc Current Assets
Nabriva Therapeutics plc had Current Assets of $9.95 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-10-19
- 2023-06-30: Assets, Current $9.95M.
- 2023-03-31: Assets, Current $23.69M.
- 2022-12-31: Assets, Current $31.10M.
- 2022-09-30: Assets, Current $47.56M.
| Period end | Assets, Current |
|---|---|
| 2023-06-30 | $9.95M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $23.69M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $31.10M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $47.56M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $54.30M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $65.20M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $80.27M 10-K · filed 2023-04-17 |
| 2021-09-30 | $88.41M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $94.62M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $78.44M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $57.22M 10-K · filed 2022-03-29 |
| 2020-09-30 | $54.31M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $62.41M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $38.17M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $91.17M 10-K · filed 2021-03-11 |
| 2019-09-30 | $86.41M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $80.09M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $100.48M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $108.75M 10-K · filed 2020-03-12 |
| 2018-09-30 | $110.68M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $84.95M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $98.50M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $93.84M 10-K · filed 2019-03-12 |
| 2017-09-30 | $117.87M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $63.23M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $76.58M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $90.62M 10-K · filed 2018-03-16 |
| 2015-12-31 | $116.25M 10-K · filed 2017-03-24 |